Clinical Trial Update: Vaccine Therapy in Treating Patients With Primary Stage II Melanoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of a vaccine therapy for primary stage II melanoma is underway, but the current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Vaccine Therapy (Phase 3 trial)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Melanoma (Skin) | Phase 3 | Status: UNKNOWN